{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:38:59Z","timestamp":1761561539493,"version":"3.41.2"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/igc.0b013e31821a2567","type":"journal-article","created":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T03:24:35Z","timestamp":1306898675000},"page":"911-917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Expression of Survivin, CD117, and C-erbB-2 in Neuroendocrine Carcinoma of the Uterine Cervix"],"prefix":"10.1016","volume":"21","author":[{"given":"Kornkanok","family":"Sukpan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jongkolnee","family":"Settakorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surapan","family":"Khunamornpong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chalong","family":"Cheewakriangkrai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jatupol","family":"Srisomboon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumalee","family":"Siriaunkgul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2003","series-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs","key":"10.1097\/IGC.0b013e31821a2567_bb0005"},{"key":"10.1097\/IGC.0b013e31821a2567_bb0010","first-page":"34","article-title":"Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute","volume":"121","author":"Albores-Saavedra","year":"1997","journal-title":"Arch Pathol Lab Med."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0015","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1470-2045(09)70368-7","article-title":"Targeted therapies for rare gynaecological cancers","volume":"11","author":"Manchana","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0020","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/ijc.20768","article-title":"Nuclear or cytoplasmic expression of survivin: what is the significance?","volume":"114","author":"Li","year":"2005","journal-title":"Int J Cancer."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0025","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1158\/1535-7163.MCT-05-0375","article-title":"Survivin, a cancer target with an emerging role in normal adult tissues","volume":"5","author":"Fukuda","year":"2006","journal-title":"Mol Cancer Ther."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0030","first-page":"188","article-title":"Characterization of c-kit expression in small cell lung cancer: prognostic and therapeutic implications","volume":"9","author":"Micke","year":"2003","journal-title":"Clin Cancer Res."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0169-5002(01)00488-3","article-title":"Predictive role of HER-2\/ neu overexpression and clinical features at initial presentation in patients with extensive stage small cell lung carcinoma","volume":"36","author":"Potti","year":"2002","journal-title":"Lung Cancer."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0377-4929.59173","article-title":"Immunohistochemical study of p16 INK4A and survivin expressions in cervical squamous neoplasm","volume":"53","author":"Tan","year":"2010","journal-title":"Indian J Pathol Microbiol."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/ijgc-00009577-200501000-00017","article-title":"Survivin, a novel anti-apoptosis inhibitor, expression in uterine cervical cancer and relationship with prognostic factors","volume":"15","author":"Lee","year":"2005","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0050","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ygyno.2006.07.011","article-title":"Survivin protein expression and hypoxia in advanced cervical carcinoma of patients treated by radiotherapy","volume":"104","author":"Bache","year":"2007","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0055","first-page":"3319","article-title":"The selective tyrosine kinase inhibitor STI571 inhibits small cell lung cancer growth","volume":"6","author":"Krystal","year":"2000","journal-title":"Clin Cancer Res."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0060","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1038\/sj.onc.1203698","article-title":"Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571","volume":"19","author":"Wang","year":"2000","journal-title":"Oncogene."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0065","first-page":"53","article-title":"C-kit overexpression in neuroendocrine small cell carcinoma of the uterine cervix","volume":"27","author":"Ohwada","year":"2006","journal-title":"Eur J Gynaecol Oncol."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0070","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/modpathol.3800112","article-title":"Overexpression of c-kit protein is an infrequent event in small cell carcinomas of the uterine cervix","volume":"17","author":"Wang","year":"2004","journal-title":"Mod Pathol."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0075","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s004320050248","article-title":"Prognostic significance of c-erbB-2 protein expression in carcinoma of the cervix treated with radiotherapy","volume":"125","author":"Nishioka","year":"1999","journal-title":"J Cancer Res Clin Oncol."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/1097-0142(19940101)73:1<148::AID-CNCR2820730125>3.0.CO;2-C","article-title":"Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix","volume":"73","author":"Kihana","year":"1994","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0085","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1002\/1097-0142(19950515)75:10<2523::AID-CNCR2820751019>3.0.CO;2-L","article-title":"Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix","volume":"75","author":"Mandai","year":"1995","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0090","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1006\/gyno.2001.6385","article-title":"Predictors of outcome in small cell carcinoma of the cervixVa case series","volume":"83","author":"Straughn","year":"2001","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0095","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/ijgc-00009577-200507000-00011","volume":"15","author":"Tangjitgamol","year":"2005","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0100","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/annonc\/mdm465","article-title":"Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study","volume":"19","author":"Lee","year":"2008","journal-title":"Ann Oncol."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0105","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/modpathol.2008.61","article-title":"Nuclear expression of survivin portends a poor prognosis in Merkel cell carcinoma","volume":"21","author":"Kim","year":"2008","journal-title":"Mod Pathol."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000084892","article-title":"Nuclear survivin is a powerful novel prognostic marker in gastroenteropancreatic neuroendocrine tumor disease","volume":"81","author":"Grabowski","year":"2005","journal-title":"Neuroendocrinology."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0115","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/sj.bjc.6601402","article-title":"Survivin expression in oral squamous cell carcinoma","volume":"89","author":"Lo Muzio","year":"2003","journal-title":"Br J Cancer."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.surg.2004.05.023","article-title":"Survivin expression is a prognostic marker in pancreatic cancer patients","volume":"136","author":"Kami","year":"2004","journal-title":"Surgery."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0125","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.bjc.6604192","article-title":"Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer","volume":"98","author":"Preuss","year":"2008","journal-title":"Br J Cancer."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0130","first-page":"440","article-title":"Survivin expression in oesophageal squamous cell carcinoma: its prognostic impact and splice variant expression","volume":"37","author":"Takeno","year":"2010","journal-title":"Eur J Cardiothorac Surg."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0135","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ygyno.2006.10.005","article-title":"Correlation between survivin expression and locoregional control in cervical squamous cell carcinomas treated with radiation therapy","volume":"104","author":"Suzuki","year":"2007","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/emm.2006.28","article-title":"Antisurvivin oligonucleotides inhibit growth and induce apoptosis in human medullary thyroid carcinoma cells","volume":"38","author":"Du","year":"2006","journal-title":"Exp Mol Med."},{"key":"10.1097\/IGC.0b013e31821a2567_bb0145","first-page":"207","article-title":"Expressions of FEZ1 and survivin and their significance in small cell lung cancer and squamous cell lung carcinoma. Chinese-German","volume":"7","author":"Chen","year":"2008","journal-title":"Journal of Clinical Oncology."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24045481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24045481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:17:54Z","timestamp":1753233474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24045481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1048891X24045481"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e31821a2567","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of Survivin, CD117, and C-erbB-2 in Neuroendocrine Carcinoma of the Uterine Cervix","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e31821a2567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2011 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}